Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-23

Clinical Trial Update: Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial of Omega Interferon alone or in combination with Ribavirin for Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega Interferon (interferon omega)
  • Ribavirin (ribavirin)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED